Archives 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 February 15, 2016 First US Patients Commence Dosing in Lupuzor’s™ Pivotal Phase III Study Read More February 05, 2016 Placing and Subscription Raises £8.3 million Read More February 05, 2016 Proposed Placing and Subscription and Notice of General Meeting: 22 February 2016 Read More December 15, 2015 Over 70 Lupus Specialists Gather in Paris for Lupuzor’s™ Phase III Investigators Meeting Read More December 07, 2015 Lupuzor™ Pivotal Phase III Trial Recruiting First US Lupus Patients Read More November 04, 2015 Lupuzor™ Phase III Pivotal Trial Update Read More October 23, 2015 Board Change Read More September 30, 2015 Tim McCarthy Appointed as Non-executive Chairman Read More September 30, 2015 Interim Results Announcement for the six months ended 30 June 2015 Read More July 29, 2015 Richard Warr Read More July 27, 2015 ClinicalTrials.Gov registration of LUPUZOR™ Pivotal Phase III Trial Read More July 25, 2015 Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™ Read More 1…1213141516…18
February 05, 2016 Proposed Placing and Subscription and Notice of General Meeting: 22 February 2016 Read More
December 15, 2015 Over 70 Lupus Specialists Gather in Paris for Lupuzor’s™ Phase III Investigators Meeting Read More
July 25, 2015 Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™ Read More
